An Zwijsen

6.2k citations
87 papers · 4.7k indexed · h-index 35
Topics
TGF-β signaling in diseases (33 papers)Congenital heart defects research (20 papers)Pluripotent Stem Cells Research (14 papers)

In The Last Decade

An Zwijsen

85 papers receiving 4.7k citations

Peers

An Zwijsen
Comparison fields: 5 of 125
  • Molecular Biology 3.4k
  • Surgery 539
  • Cell Biology 512
  • Physiology 477
  • Genetics 457
Replace Takumi Era with:
Takumi Era Japan
Per Levéen Sweden
Jody J. Haigh Belgium
Tetsuro Watabe Japan
Tsutomu Kume United States
Thorsten M. Schlaeger United States
Johanna Andræ Sweden
Stephen Meek United Kingdom
Paul Gadue United States
Victoria L. Bautch United States
An Zwijsen relative to Takumi Era Japan Takumi Era's profile →
Citations per field
00.5×
Takumi Era · 1×
Citations per year

Countries citing papers authored by An Zwijsen

Since Specialization
Citations

This map shows the geographic impact of An Zwijsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Zwijsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Zwijsen more than expected).

Fields of papers citing papers by An Zwijsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Zwijsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Zwijsen. The network helps show where An Zwijsen may publish in the future.

Co-authorship network of co-authors of An Zwijsen

This figure shows the co-authorship network connecting the top 25 collaborators of An Zwijsen. A scholar is included among the top collaborators of An Zwijsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Zwijsen. An Zwijsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 0
3 12
4 13
5 16
6 22
7 22
8 12
9 137
10 73
11 67
12 86
13 76
14 35
15
The extracellular matrix 1 gene is essential for early mouse development
2
16 37
17 12
18 208
19 19
20 29

About An Zwijsen

An Zwijsen is a scholar working on Molecular Biology, Genetics and Cell Biology, having authored 87 papers that have together received 4.7k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (33 papers), Congenital heart defects research (20 papers) and Pluripotent Stem Cells Research (14 papers). The work is most often cited by research in Molecular Biology (3.4k citations), Genetics (457 citations) and Cell Biology (512 citations). An Zwijsen has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Danny Huylebroeck, Lieve Umans, Martin M. Matzuk, Kristin Verschueren, Hua Chang, Paulo N. G. Pereira, Christine L. Mummery, Marie‐José Goumans, Qiuxia Guo and Richard R. Behringer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026